Updates from The Motley Fool

Latest updates on Biocept, Inc. from Fool.com.

There is no available coverage of Biocept, Inc. at this time.



Stock Performance

BIOC vs. S&P 500 | 2 Year Performance
BIOC 1-Day Stock Chart
BIOC 5-Day Stock Chart
BIOC 1-Month Stock Chart
BIOC 3-Month Stock Chart
BIOC 6-Month Stock Chart
BIOC 1-Year Stock Chart
BIOC 2-Year Stock Chart
BIOC 5-Year Stock Chart
View Interactive BIOC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Biocept, Inc..
Current Price: $0.95
Prev Close: $1.02
Open: $1.04
Bid: $0.66
Ask: $1.33
Day's Range: $0.94 - $1.04
52wk Range: $0.94 - $3.70
Volume: 554,394
Avg Vol 209,284
Market Cap: $17.89M
P/E (ttm): -1.00
EPS (ttm): -$1.02
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Biocept, Inc..
CAPS Rating 1 out of 5
 
10 Outperform
8 Underperform
CAPS All Stars
 
1 Outperform
5 Underperform

How do you think Biocept, Inc. will perform against the market?



You pick for Biocept, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael Nall, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Biocept, Inc..

The company is a provider of integrated clinical research technology solutions to pharmaceutical biotechnology and medical device companies and other organizations.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT